18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
or 9 11 9 11 O
older 12 17 12 17 O

4 0 1 18 19 B-upper_bound
weeks 2 7 20 25 I-upper_bound
from 8 12 26 30 O
prior 13 18 31 36 B-treatment
chemotherapy 19 31 37 49 I-treatment
( 32 33 50 51 O
6 34 35 52 53 B-upper_bound
weeks 36 41 54 59 I-upper_bound
for 42 45 60 63 O
mitomycin 46 55 64 73 B-treatment
C 56 57 74 75 I-treatment
and 58 61 76 79 O
nitrosourea 62 73 80 91 B-treatment
) 73 74 91 92 O
, 75 76 93 94 O
immunotherapy 77 90 95 108 B-treatment
, 90 91 108 109 O
investigational 92 107 110 125 B-treatment
anti 108 112 126 130 I-treatment
- 112 113 130 131 I-treatment
cancer 113 119 131 137 I-treatment
therapy 120 127 138 145 I-treatment
, 127 128 145 146 O
radiation 129 138 147 156 B-treatment
therapy 139 146 157 164 I-treatment
; 146 147 164 165 O
and 148 151 166 169 O
have 152 156 170 174 O
recovered 157 166 175 184 O
from 167 171 185 189 O
prior 172 177 190 195 O
toxicities 178 188 196 206 O

Agree 0 5 207 212 B-contraception_consent
to 6 8 213 215 I-contraception_consent
practice 9 17 216 224 I-contraception_consent
effective 18 27 225 234 I-contraception_consent
contraception 28 41 235 248 I-contraception_consent

At 0 2 249 251 O
least 3 8 252 257 O
4 9 10 258 259 B-upper_bound
weeks 11 16 260 265 I-upper_bound
from 17 21 266 270 O
major 22 27 271 276 B-treatment
surgery 28 35 277 284 I-treatment

Currently 0 9 285 294 O
receiving 10 19 295 304 O
radiotherapy 20 32 305 317 B-treatment
, 32 33 317 318 O
biological 34 44 319 329 B-treatment
therapy 45 52 330 337 I-treatment
, 52 53 337 338 O
or 54 56 339 341 O
any 57 60 342 345 O
other 61 66 346 351 O
investigational 67 82 352 367 B-treatment
agents 83 89 368 374 I-treatment

ECOG 0 4 375 379 B-clinical_variable
performance 5 16 380 391 I-clinical_variable
status 17 23 392 398 I-clinical_variable
0 24 25 399 400 B-lower_bound
- 25 26 400 401 O
1 26 27 401 402 B-upper_bound

Histologically 0 14 403 417 O
or 15 17 418 420 O
cytologically 18 31 421 434 O
confirmed 32 41 435 444 O
solid 42 47 445 450 B-cancer
tumors 48 54 451 457 I-cancer
or 55 57 458 460 O
lymphomas 58 67 461 470 B-cancer
that 68 72 471 475 I-cancer
is 73 75 476 478 I-cancer
metastatic 76 86 479 489 I-cancer
or 87 89 490 492 O
unresectable 90 102 493 505 O
and 103 106 506 509 O
for 107 110 510 513 O
which 111 116 514 519 O
standard 117 125 520 528 O
curative 126 134 529 537 O
or 135 137 538 540 O
palliative 138 148 541 551 O
measures 149 157 552 560 O
do 158 160 561 563 O
not 161 164 564 567 O
exist 165 170 568 573 O
or 171 173 574 576 O
are 174 177 577 580 O
no 178 180 581 583 O
longer 181 187 584 590 O
effective 188 197 591 600 O

Known 0 5 601 606 O
active 6 12 607 613 B-chronic_disease
hepatitis 13 22 614 623 I-chronic_disease
B 23 24 624 625 I-chronic_disease
and/or 25 31 626 632 O
hepatitis 32 41 633 642 B-chronic_disease
C 42 43 643 644 I-chronic_disease
infection 44 53 645 654 I-chronic_disease

Known 0 5 655 660 O
to 6 8 661 663 O
be 9 11 664 666 O
HIV 12 15 667 670 B-chronic_disease
- 15 16 670 671 O
positive 16 24 671 679 O

Life 0 4 680 684 B-clinical_variable
expectancy 5 15 685 695 I-clinical_variable
â‰¥ 16 17 696 697 O
3 18 19 698 699 B-lower_bound
months 20 26 700 706 I-lower_bound

Pregnant 0 8 707 715 B-pregnancy

Previously 0 10 716 726 O
untreated 11 20 727 736 O
CNS 21 24 737 740 B-cancer
metastasis 25 35 741 751 I-cancer
or 36 38 752 754 O
progressive 39 50 755 766 O
CNS 51 54 767 770 O
metastasis 55 65 771 781 O

Uncontrolled 0 12 782 794 O
intercurrent 13 25 795 807 B-chronic_disease
illness 26 33 808 815 I-chronic_disease

lactating 0 9 816 825 O
women 10 15 826 831 B-gender

